Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail
-
-

Science Board to the Food and Drug Administration

Purpose

The Board shall provide advice primarily to the Commissioner and other appropriate officials on specific complex and technical issues as well as, emerging issues within the scientific community, in industry and academia.  Additionally, the Board will provide advice to the Agency on keeping pace with technical and scientific evolutions in the fields of regulatory science, or formulating an appropriate research agendas; upgrading its scientific and research facilities to keep pace with these changes.  It will also provide the means for critical review of Agency sponsored intramural and extramural scientific research programs.

Committee Membership

The Committee shall consist of a core of 21 voting members including a Chair and a Co-Chair. The members, Chair, and Co-Chair are selected by the Commissioner or designee from among authorities knowledgeable in the fields of food safety, nutrition, chemistry, pharmacology, toxicology, clinical research or systems biology, healthcare devices, nanotechnology, medical imaging, robotics, cell and tissue based products, regenerative medicine, and combination products. Almost all non-Federal members of this committee serve as Special Government Employees. The core of voting members may include 1 technically qualified member, selected by the Commissioner or designee, who is identified with consumer interests and is recommended by either a consortium of consumer-oriented organizations or other interested persons. The Committee may also include technically qualified federal members.

Contact Information

Martha Monser, Designated Federal Officer
Office of the Chief Scientist
Office of the Commissioner
WO Bldg. 32, Room 4286
10903 New Hampshire Ave.
Silver Spring, Maryland, 20993
Phone: 301-796-4627
Fax: 301-847-8617
Email: martha.monser@fda.hhs.gov
 

FDA Advisory Committee Information Line

1-800-741-8138
(301-443-0572 in the Washington, DC, area)
code 3014512603
Please call the Information Line for up-to-date information on meetings

-
-
-